ArticleUrolithiasis2025
Improved 24-hour urine parameters associated with reduced symptomatic kidney stone recurrence.
Article in Urolithiasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
On-treatment 24-h urine testing rates are low outside of tertiary care centers. A common criticism is the paucity of evidence demonstrating the optimization of urinary parameters correlates with reduced stone recurrence. Using standard and novel analytic approaches, we sought to evaluate whether improvements in 24-h urine parameters associated with decreased symptomatic stone recurrence. Kidney stone patients who underwent multiple 24-h urine tests and had an initial parameter abnormality were identified from a prospective database. A novel 24-h urine severity score was calculated at both the initial and subsequent tests and used to stratify patients. Negative binomial regression was used to evaluate the impact of analyte changes on stone recurrence. Two hundred patients met inclusion criteria. Low voided volume, hypercalciuria, hyperoxaluria, hypocitraturia and low pH were identified in 56%, 28%, 40%, 49% and 35% respectively. Patients with hypercalciuria and hypocitraturia who consistently normalized these values showed decreased recurrence (p < 0.001). Increasing initial 24-h urine severity scores associated with increased stone recurrence (0.09, 0.18 and 0.31 stone events per year for the lowest, 25-75th and highest quartiles, p < 0.001). On multivariable analysis, severity score improvement or stabilization was associated with reduced risk of recurrence across all quartiles (RRR 0.319 to 0.591, all p < 0.001). Consistent control of 24-h urine parameters was associated with decreased stone recurrence. Not only did novel 24-h urine composite severity scores based on initial 24-h urines independently predict stone recurrence, improvements in this score over time also predicted decreased recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.